Terug
Ook genoteerd als
MCVEF
OTC
Dagbereik
€ 16,55
€ 21,54
52-Weeksbereik
€ 16,55
€ 21,54
Volume
100
50D / 200D Gem.
€ 16,55
/
€ 16,55
Vorige Slotkoers
€ 16,55
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 32,2 | 0,4 |
| P/B | 4,7 | 2,9 |
| ROE % | 15,5 | 3,8 |
| Net Margin % | 3,3 | 3,9 |
| Rev Growth 5Y % | 14,6 | 10,0 |
| D/E | 2,7 | 0,2 |
Belangrijkste Punten
Revenue grew 14,63% annually over 5 years — strong growth
Earnings grew 364,07% over the past year
ROE of 15,54% — decent returns on equity
Debt/Equity of 2,70 — high leverage
Generating 185,60M in free cash flow
P/E of 32,18 — premium valuation
Groei
Revenue Growth (5Y)
14,63%
Revenue (1Y)13,69%
Earnings (1Y)364,07%
FCF Growth (3Y)40,14%
Kwaliteit
Return on Equity
15,54%
ROIC5,92%
Net Margin3,26%
Op. Margin6,55%
Veiligheid
Debt / Equity
2,70
Current Ratio0,70
Interest Coverage2,43
Waardering
P/E Ratio
32,18
P/B Ratio4,68
EV/EBITDA24,74
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,69% | Revenue Growth (3Y) | 16,69% |
| Earnings Growth (1Y) | 364,07% | Earnings Growth (3Y) | 109,84% |
| Revenue Growth (5Y) | 14,63% | Earnings Growth (5Y) | -6,59% |
| Profitability | |||
| Revenue (TTM) | 2,38B | Net Income (TTM) | 77,50M |
| ROE | 15,54% | ROA | 3,20% |
| Gross Margin | 23,16% | Operating Margin | 6,55% |
| Net Margin | 3,26% | Free Cash Flow (TTM) | 185,60M |
| ROIC | 5,92% | FCF Growth (3Y) | 40,14% |
| Safety | |||
| Debt / Equity | 2,70 | Current Ratio | 0,70 |
| Interest Coverage | 2,43 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 32,18 | P/B Ratio | 4,68 |
| P/S Ratio | 1,05 | PEG Ratio | 0,08 |
| EV/EBITDA | 24,74 | Dividend Yield | 0,01% |
| Market Cap | 2,49B | Enterprise Value | 3,85B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,38B | 2,09B | 1,75B | 1,51B | 1,38B |
| Net Income | 77,50M | 16,70M | 17,60M | 11,80M | 101,80M |
| EPS (Diluted) | 0,51 | 0,11 | 0,12 | 0,08 | 0,69 |
| Gross Profit | 550,70M | 448,30M | 359,40M | 335,30M | 395,00M |
| Operating Income | 155,70M | 70,30M | 61,40M | 55,20M | 159,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,42B | 2,14B | 1,94B | 1,83B | 1,68B |
| Total Liabilities | 1,88B | 1,65B | 1,41B | 1,32B | 1,12B |
| Shareholders' Equity | 532,80M | 464,80M | 496,50M | 472,40M | 517,60M |
| Total Debt | 1,44B | 1,24B | 1,00B | 940,00M | 764,10M |
| Cash & Equivalents | 82,30M | 69,80M | 50,80M | 40,40M | 81,90M |
| Current Assets | 496,50M | 446,70M | 381,30M | 334,20M | 551,60M |
| Current Liabilities | 707,70M | 566,30M | 500,60M | 356,40M | 325,00M |